FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2568592844> ?p ?o ?g. }

• W2568592844 endingPage "13374" @default.
• W2568592844 startingPage "13367" @default.
• W2568592844 abstract "The appropriate number of chemotherapy cycles for limited stage diffuse large B-cell lymphoma (DLBCL) patients without gross residual lesions after complete resection, has not been specifically questioned. We performed a multicenter, single-arm, phase 2 study to investigate the feasibility of 3 cycles of abbreviated R-CHOP chemotherapy in low-risk patients with completely resected localized CD20+ DLBCL.Between December 2010 and May 2013, we recruited 23 patients. One was excluded due to ineligibility, and hence, 22 were included in the final analysis. The primary sites comprised the intestine (n = 15), cervical lymph nodes (n = 4), stomach (n = 1), tonsil (n = 1), and spleen (n = 1). All patients successfully completed the 3 cycles of planned R-CHOP chemotherapy. Over a median follow-up of 39.5 months (95% confidence interval, 29.9-47.1 months), both the estimated 2-year disease-free survival and overall survival rates was 95% confidence interval, 85.9-104.1%. Only one patient with an international prognostic index of 2 experienced relapse and died. The most common grade 3 or 4 toxicity condition included neutropenia (n = 8, 36.4%). Three patients experienced grade 3 febrile neutropenia, but no grade 3 or 4 non-hematologic toxicity was observed.DLBCL patients without residual lesions after resection were enrolled and R-CHOP chemotherapy was repeated at 3-week-intervals over 3 cycles. The primary endpoint was 2-year disease-free survival.Three cycles of abbreviated R-CHOP immunochemotherapy is feasible for completely resected low risk localized DLBCL." @default.
• W2568592844 created "2017-01-13" @default.
• W2568592844 creator A5015908436 @default.
• W2568592844 creator A5022379369 @default.
• W2568592844 creator A5044958787 @default.
• W2568592844 creator A5046987994 @default.
• W2568592844 creator A5075932421 @default.
• W2568592844 creator A5082144323 @default.
• W2568592844 creator A5082389619 @default.
• W2568592844 creator A5089689144 @default.
• W2568592844 date "2017-01-05" @default.
• W2568592844 modified "2023-09-25" @default.
• W2568592844 title "Feasibility of abbreviated cycles of immunochemotherapy for completely resected limited-stage CD20+ diffuse large B-cell lymphoma (CISL 12-09)" @default.
• W2568592844 cites W1094999820 @default.
• W2568592844 cites W1828224642 @default.
• W2568592844 cites W1898697707 @default.
• W2568592844 cites W1964451804 @default.
• W2568592844 cites W1976347407 @default.
• W2568592844 cites W1989462574 @default.
• W2568592844 cites W2015214739 @default.
• W2568592844 cites W2020789296 @default.
• W2568592844 cites W2022254172 @default.
• W2568592844 cites W2058015212 @default.
• W2568592844 cites W2092050904 @default.
• W2568592844 cites W2106928992 @default.
• W2568592844 cites W2118764394 @default.
• W2568592844 cites W2123439935 @default.
• W2568592844 cites W2133201432 @default.
• W2568592844 cites W2136280704 @default.
• W2568592844 cites W2144002645 @default.
• W2568592844 cites W2158267770 @default.
• W2568592844 cites W2166900358 @default.
• W2568592844 cites W2167556523 @default.
• W2568592844 cites W2171356556 @default.
• W2568592844 cites W2327610290 @default.
• W2568592844 cites W2475270667 @default.
• W2568592844 doi "https://doi.org/10.18632/oncotarget.14531" @default.
• W2568592844 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5355104" @default.
• W2568592844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28076329" @default.
• W2568592844 hasPublicationYear "2017" @default.
• W2568592844 type Work @default.
• W2568592844 sameAs 2568592844 @default.
• W2568592844 citedByCount "6" @default.
• W2568592844 countsByYear W25685928442020 @default.
• W2568592844 countsByYear W25685928442021 @default.
• W2568592844 countsByYear W25685928442022 @default.
• W2568592844 crossrefType "journal-article" @default.
• W2568592844 hasAuthorship W2568592844A5015908436 @default.
• W2568592844 hasAuthorship W2568592844A5022379369 @default.
• W2568592844 hasAuthorship W2568592844A5044958787 @default.
• W2568592844 hasAuthorship W2568592844A5046987994 @default.
• W2568592844 hasAuthorship W2568592844A5075932421 @default.
• W2568592844 hasAuthorship W2568592844A5082144323 @default.
• W2568592844 hasAuthorship W2568592844A5082389619 @default.
• W2568592844 hasAuthorship W2568592844A5089689144 @default.
• W2568592844 hasBestOaLocation W25685928441 @default.
• W2568592844 hasConcept C126322002 @default.
• W2568592844 hasConcept C141071460 @default.
• W2568592844 hasConcept C143998085 @default.
• W2568592844 hasConcept C203092338 @default.
• W2568592844 hasConcept C2776694085 @default.
• W2568592844 hasConcept C2777063308 @default.
• W2568592844 hasConcept C2778476033 @default.
• W2568592844 hasConcept C2778559949 @default.
• W2568592844 hasConcept C2778850193 @default.
• W2568592844 hasConcept C2779338263 @default.
• W2568592844 hasConcept C2779725641 @default.
• W2568592844 hasConcept C44249647 @default.
• W2568592844 hasConcept C535046627 @default.
• W2568592844 hasConcept C71924100 @default.
• W2568592844 hasConcept C90924648 @default.
• W2568592844 hasConceptScore W2568592844C126322002 @default.
• W2568592844 hasConceptScore W2568592844C141071460 @default.
• W2568592844 hasConceptScore W2568592844C143998085 @default.
• W2568592844 hasConceptScore W2568592844C203092338 @default.
• W2568592844 hasConceptScore W2568592844C2776694085 @default.
• W2568592844 hasConceptScore W2568592844C2777063308 @default.
• W2568592844 hasConceptScore W2568592844C2778476033 @default.
• W2568592844 hasConceptScore W2568592844C2778559949 @default.
• W2568592844 hasConceptScore W2568592844C2778850193 @default.
• W2568592844 hasConceptScore W2568592844C2779338263 @default.
• W2568592844 hasConceptScore W2568592844C2779725641 @default.
• W2568592844 hasConceptScore W2568592844C44249647 @default.
• W2568592844 hasConceptScore W2568592844C535046627 @default.
• W2568592844 hasConceptScore W2568592844C71924100 @default.
• W2568592844 hasConceptScore W2568592844C90924648 @default.
• W2568592844 hasIssue "8" @default.
• W2568592844 hasLocation W25685928441 @default.
• W2568592844 hasLocation W25685928442 @default.
• W2568592844 hasLocation W25685928443 @default.
• W2568592844 hasLocation W25685928444 @default.
• W2568592844 hasOpenAccess W2568592844 @default.
• W2568592844 hasPrimaryLocation W25685928441 @default.
• W2568592844 hasRelatedWork W1641876683 @default.
• W2568592844 hasRelatedWork W2018370326 @default.
• W2568592844 hasRelatedWork W2143935650 @default.
• W2568592844 hasRelatedWork W2167517071 @default.
• W2568592844 hasRelatedWork W2241365426 @default.

• next